SD大鼠骨髓基质干细胞体外诱导成骨分化实验研究  

Experimental study of SD rats bone marrow stromal cells induced into osteoblasts in vitro

作　　者：曾铁功[1] 赵晋英[1] 黄泽智[1] 

机构地区：[1]邵阳医学高等专科学校,邵阳市分子生物学重点实验室,湖南邵阳422000

出　　处：《山东医药》2013年第20期29-31,35,I0002,F0003,共6页Shandong Medical Journal

基　　金：湖南省科技厅研究项目(2011SK3035)

摘　　要：目的探讨SD大鼠骨髓基质干细胞(BMSCs)在体外诱导分化为成骨细胞的实验条件及方法。方法无菌取SD大鼠股骨骨髓,用全骨髓贴壁法体外培养纯化BMSCs,分为实验组和对照组。实验组采用第3代细胞经含地塞米松、β-甘油磷酸钠和维生素C的成骨诱导液进行诱导,对照组不加诱导液。采用MTT法绘制细胞生长曲线,BCIP/NBT试剂行碱性磷酸酶(ALP)染色,茜素红染色观察钙结节。结果与对照组比较,实验组大鼠BMSCs经成骨诱导液诱导后,细胞生长缓慢并向成骨细胞发展;实验组ALP染色阳性率为88.34%±8.65%,对照组为28.14%±5.38%,P<0.01;实验组茜素红染色第13天可见橘红色的阳性钙结节,对照组几乎为无色。结论 SD大鼠BMSCs经诱导在体外可稳定地定向分化为成骨细胞。Objective To study the osteogenic methods and cultural conditions of the SD rats bone marrow stromal cells（BMSCs） induced into osteoblasts in vitro.Methods After obtaining abacterial bone marrow from SD rats femur,the BMSCs were separated and purified by using of whole bone marrow adherent method.Then they were divided into two groups： the experimental group and the control group.In the experimental group,the passage cells of the third generation were cultured in the osteogenic induction medium including dexamethasone,β-sodium glycerophosphate and vitamin C.The growth curve of cultural cells was drawn by MTT colorimetric method.The alkaline phosphatase（ALP） staining of cultural cells was conducted by BCIP/NBT.Calcium tubercle was stained with alizarin bordeaux.The two groups were compared.Results Compared with the control group,the growth velocity of BMSCs cultured in osteogenic induction medium in the experimental group was obviously lower than that in the control group,and BMSCs developed into osteoblasts.The ALP positive rate in the experimental group was 88.34%±8.65%,and the control group was 28.14%±5.38%（P〈0.01）.On the 13th day,the positive orange-red calcium nodules in the experimental group were found,while the control group was almost colorless.Conclusion BMSCs of SD rats have the potential of being induced into the osteoblasts when cultured in vitro.

关 键 词：骨髓基质干细胞 成骨细胞 细胞分化 

分 类 号：R394.2[医药卫生—医学遗传学]